FGF2 and brain infarction: This is underscored by the fact that bFGF treatment in an animal model of SCI led only to ambiguous results and administration of bFGF to patients with brain infarction exhibited serious adverse effects, such as decreased blood pressure and increased numbers of leukocytes due to enhanced proliferation of inflammatory cells [13].